市場調査レポート
商品コード
1159381
腎バイオマーカーの世界市場(2022年~2028年)Renal Biomarker Market 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
腎バイオマーカーの世界市場(2022年~2028年) |
出版日: 2022年10月19日
発行: Orion Market Research
ページ情報: 英文 105 Pages
納期: 2~3営業日
|
世界の腎バイオマーカーの市場規模は、予測期間中に8.7%のCAGRで成長すると予測されています。当市場を牽引する主な要因には、高齢者層における腎疾患の発生率の急速な上昇などがあります。
当レポートでは、世界の腎バイオマーカー市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、セグメント別、地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。
Global Renal Biomarker Market Size, Share & Trends Analysis Report by Type (Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Pharmacodynamic Biomarkers), by Diagnostic technique (Elisa, Colorimetric Assay, Liquid Chromatography-Mass Spectrometry, Particle-Enhanced Turbidimetric Immunoassay), and by End-User Industry (Hospitals, Diagnostic Labs, Research Centers) Forecast (2022-2028)
The global renal biomarker market is anticipated to grow at a considerable CAGR of 8.7% during the forecast period. Kidney disease or renal disease is one of the major causes of death across the globe. The incidence of renal diseases, particularly in the geriatric population is rising rapidly owing to better life expectancy due to improvements in medical systems. Research and development activities undertaken by the biomarker manufacturers have led to the identification of novel renal biomarkers for delivering better diagnostic accuracy and for improving patient outcomes.
Global Renal biomarker is segmented based on type, diagnostic technique, and end-users. Based on type, the market is further diversified into diagnostic biomarkers, prognostic biomarkers, predictive biomarkers, and pharmacodynamic biomarkers. Based on the diagnostic technique, the market is bifurcated into Elisa, colorimetric assay, liquid chromatography-mass spectrometry, and particle-enhanced turbidimetric immunoassay. Based on the End-Users, the market is bifurcated into the hospitals, diagnostic labs, and research centers.
Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to hold a prominent share in the renal biomarker market during the forecast period owing to the presence of high-quality healthcare infrastructure. In addition, the prevalence rate of renal diseases is high in this region. According to the US Department of Health and Human Services, nearly 786,000 people in the United States are living with ESKD, also known as an end-stage renal disease (ESRD), with 71.0% on dialysis and 29.0% with a kidney transplant. Moreover, Europe is another significant market and holds a considerable market share in the global renal biomarker market.
The major companies serving the global renal biomarker market include Abbott Laboratories, Bayer AG, Novartis AG, Pacific Biomarkers, Siemens AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2020, Baxter International Inc. announced a distribution agreement with Biomerieux for the NEPHROCLEAR CCL14 diagnostic test in Europe and US.
Research Methodology
The market study of the global renal biomarker market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers: